Form 6-K ASTRAZENECA PLC For: Oct 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
AstraZeneca (AZN) Confirms FDA Partial Clinical Hold Placed on Patient Recruitment for MEDI4736 Trial in HNSCC; Issues Commentary
October 27, 2016 2:47 PM EDTAstraZeneca (NYSE: AZN) issued the following statement following news that recruitment for its study of MEDI4736 (Durvaluma) in head and neck cancer was halted:
Following the... More
